The Study of Effective Factors on Iran's Pharmaceutical Export Supply and Demand.

demand export pharmaceutical industry supply

Journal

Iranian journal of pharmaceutical research : IJPR
ISSN: 1735-0328
Titre abrégé: Iran J Pharm Res
Pays: Netherlands
ID NLM: 101208407

Informations de publication

Date de publication:
2019
Historique:
entrez: 19 3 2020
pubmed: 19 3 2020
medline: 19 3 2020
Statut: ppublish

Résumé

The importance of drug as a valuable export product in the global economy becomes clearer every day. Understanding the problems of exports and factors affecting it, can be an important step to keep Iran's position in the world markets and further export development of this product. In this study, Iranian pharmaceutical exports' supply and demand functions were calculated using co-integration and error correction techniques through time series quarterly data of 2000-2014 in order to identify the factors affecting pharmaceutical exports (short run and long run relationships among the variables) and price and income elasticities. The long run price elasticity of demand of -2.28 indicates that an increase in Iran's export price relative to competitor's export price will have a negative impact on pharmaceutical export volume. Also, the long run income elasticity of foreign demand for pharmaceutical exports of Iran is 1.11. That is an increase in income of foreign countries will have a positive impact on Iran's pharmaceutical export. On the other hand, the long run price elasticity of export supply is 1.09, indicating that the supply of pharmaceutical export is sensitive to the relative price changes. In other words, an increase in export price relative to domestic price as well as an expansion of the pharmaceutical production capacity will increase its export supply. Being aware of the factors affecting the pharmaceutical exports can prepare the ground to develop the pharmaceutical industry and balance the supply and demand in the long run. Therefore, the results of this study can help Iran's policymakers and managers to choose a clearer path for the pharmaceutical trade policies.

Identifiants

pubmed: 32184887
doi: 10.22037/ijpr.2019.1100841
pmc: PMC7059051
doi:

Types de publication

Journal Article

Langues

eng

Pagination

2226-2232

Références

Daru. 2013 Jun 28;21(1):52
pubmed: 23805853
Iran J Pharm Res. 2013 Winter;12(1):249-55
pubmed: 24250597
Iran J Pharm Res. 2019 Winter;18(1):546-555
pubmed: 31089388
Glob J Health Sci. 2015 Apr 23;7(6):295-307
pubmed: 26153184
Glob J Health Sci. 2015 Mar 30;7(5):311-9
pubmed: 26156931
Iran J Pharm Res. 2018 Spring;17(2):822-828
pubmed: 29881438

Auteurs

Behzad Najafi (B)

Department of Health Economics, School of Management and Medical Informatics, Tabriz University of Medical Sciences, Tabriz, Iran.

Alireza Mahboub-Ahari (A)

Department of Health Economics, School of Management and Medical Informatics, Tabriz University of Medical Sciences, Tabriz, Iran.

Soraya Nouraei Motlagh (S)

Department of Public Health, School of Health and Nutrition, Lorestan University of Medical Sciences,Khorramabad, Iran.

Seyed Alireza Otobideh (SA)

Department of Health Economics and Management, School of Health, Urmia University of Medical Sciences, Urmia, Iran.

Bahlol Rahimi (B)

Department of Health Information Technology, School of Allied Medical Sciences, Urmia Medical Sciences University, Urmia, Iran.

Hosein Shabaninejad (H)

Institute of Health and Society (IHS), Newcastle University, Newcastle, United Kingdom.

Hasan Yusefzadeh (H)

Department of Health Economics and Management, School of Health, Urmia University of Medical Sciences, Urmia, Iran.

Classifications MeSH